Ignite Creation Date:
2024-05-06 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05082025
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-10
First Post:
2021-09-02
Brief Title:
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER andor PR Cancers With PI3K PIK3CA PIK3R1 andor PTEN Alterations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-29
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-02
First Submit QC Date:
October 5 2021
Study First Post Date:
2021-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-06
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL